Purchases and Sales Made in Q4 2022 in Verve Therapeutics, Inc. (VERV)
This table provides information about the institutional ownership of Verve Therapeutics, Inc. (VERV) during Q4 2022. The information is specifically focused on institutions that hold shares of Verve Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-149K- 90.16% |
$2.66M - $6.06M
|
16.3K
$139K
|
|
|
Feb 13, 2023
Q4 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-152K- 15.0% |
$2.71M - $6.17M
|
859K
$7.37M
|
|
|
Feb 14, 2023
Q4 2022
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-250K- 41.67% |
$4.46M - $10.2M
|
350K
$3M
|
|
|
Feb 14, 2023
Q4 2022
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-283K- 18.82% |
$5.06M - $11.5M
|
1.22M
$10.5M
|
|
|
Feb 13, 2023
Q4 2022
|
Alphabet Inc.
Mountain View, CA |
SELL
|
- |
-425K- 3.87% |
$7.58M - $17.3M
|
10.5M
$90.5M
|
|
|
Feb 14, 2023
Q4 2022
|
Casdin Capital, LLC
New York, NY |
SELL
|
- |
-888K- 27.93% |
$15.8M - $36.1M
|
2.29M
$19.7M
|
|
|
Feb 14, 2023
Q4 2022
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-952K- 81.41% |
$17M - $38.7M
|
217K
$1.86M
|